NervGen Pharma (NGEN.V) Stock Price
NervGen Pharma Price
The consensus 12-month price target for NervGen Pharma is 8.01 CAD, about 259.6% above where the stock trades today. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus.
NervGen Pharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
NervGen Pharma business model & stock analysis
Frequently asked questions about NervGen Pharma
Analysts currently set an average price target of 7.75 CAD for the NervGen Pharma stock (median: 8.01 CAD), implying +248.2 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the NervGen Pharma stock: 7 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the NervGen Pharma share trades at 1.40 EUR (2.23 CAD).
The NervGen Pharma share (NGEN.V) is listed on 3 stock exchanges, including: Toronto (NGEN.V), Frankfurt (9UA.F).
The revenue cannot currently be calculated for NervGen Pharma.
The expected profit of NervGen Pharma is -20.90 M CAD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of NervGen Pharma is currently -7.71. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the NervGen Pharma stock.
The P/S cannot be calculated for NervGen Pharma currently.
The Eulerpool Quality Score for NervGen Pharma is 2/10.
The ISIN of NervGen Pharma is CA64082X2032. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of NervGen Pharma is A2QP3D. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of NervGen Pharma is NGEN.V. The ticker symbol is used to trade NervGen Pharma shares on the stock exchange.
NervGen Pharma stock
NervGen Pharma Peer Group
NervGen Pharma Ticker
NervGen Pharma FIGI
All fundamentals and in-depth analysis of NervGen Pharma
Our stock analysis for NervGen Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NervGen Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.